CELLS-BASEL 润色咨询

Cells

出版年份:暂无数据 年文章数:10041 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:1.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2109630, encodeId=ed9c21096301e, content=有没有战友12月底修回的,到现在还没有收到回信?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c438367317, createdName=ms3000000310137729, createdTime=Tue Jan 10 09:26:49 CST 2023, time=2023-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114776, encodeId=78812114e7685, content=under review两个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Wed Feb 15 18:13:05 CST 2023, time=2023-02-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2113622, encodeId=2792211362243, content=23年起有伙伴被cells接收吗?问了几个人,不明原因审稿后待决定pending10-40天不等,很害怕,最近又开始控制中国稿件了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230126/2c0a7a41db0c42278cbcd3d3584dc3a3/8ac4d58bd64743f599a1e014c4bb7168.jpg, createdBy=684f6549008, createdName=豌豆嘎嘣脆, createdTime=Wed Feb 08 15:30:28 CST 2023, time=2023-02-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了,这么慢吗,这是在分配编辑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113477, encodeId=dd0521134e7f6, content=要求wb整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e298427966, createdName=ms8000000060323396, createdTime=Tue Feb 07 14:48:45 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向:肠道菌群<br>经验分享:Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2089804, encodeId=8bea20898043d, content=有大修后被拒的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 22 17:04:05 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向:细胞信号;分子生物学<br>经验分享:Under review 是外审还是编辑内审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审,两个审稿人意见还好(审稿人1:接受前需要做出一些必要的修改;审稿人2:我同意接收,但需要一些改动),状态持续pending decision半个多月(这个状态似乎是不乐观?),然后状态又突然变回under review,编辑说是在寻找第三个审稿人<br>这样还有戏吗(叹气), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2106393, encodeId=e1e12106393cf, content=有没有战友一审一个月,拒稿建议修改重投啊,这种有没有戏啊,求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Fri Dec 16 21:15:43 CST 2022, time=2022-12-16, status=1, ipAttribution=重庆)]
    2023-01-10 ms3000000310137729 来自广东省

    有没有战友12月底修回的,到现在还没有收到回信?

    20

    展开20条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2109630, encodeId=ed9c21096301e, content=有没有战友12月底修回的,到现在还没有收到回信?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c438367317, createdName=ms3000000310137729, createdTime=Tue Jan 10 09:26:49 CST 2023, time=2023-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114776, encodeId=78812114e7685, content=under review两个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Wed Feb 15 18:13:05 CST 2023, time=2023-02-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2113622, encodeId=2792211362243, content=23年起有伙伴被cells接收吗?问了几个人,不明原因审稿后待决定pending10-40天不等,很害怕,最近又开始控制中国稿件了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230126/2c0a7a41db0c42278cbcd3d3584dc3a3/8ac4d58bd64743f599a1e014c4bb7168.jpg, createdBy=684f6549008, createdName=豌豆嘎嘣脆, createdTime=Wed Feb 08 15:30:28 CST 2023, time=2023-02-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了,这么慢吗,这是在分配编辑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113477, encodeId=dd0521134e7f6, content=要求wb整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e298427966, createdName=ms8000000060323396, createdTime=Tue Feb 07 14:48:45 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向:肠道菌群<br>经验分享:Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2089804, encodeId=8bea20898043d, content=有大修后被拒的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 22 17:04:05 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向:细胞信号;分子生物学<br>经验分享:Under review 是外审还是编辑内审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审,两个审稿人意见还好(审稿人1:接受前需要做出一些必要的修改;审稿人2:我同意接收,但需要一些改动),状态持续pending decision半个多月(这个状态似乎是不乐观?),然后状态又突然变回under review,编辑说是在寻找第三个审稿人<br>这样还有戏吗(叹气), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2106393, encodeId=e1e12106393cf, content=有没有战友一审一个月,拒稿建议修改重投啊,这种有没有戏啊,求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Fri Dec 16 21:15:43 CST 2022, time=2022-12-16, status=1, ipAttribution=重庆)]
    2023-02-15 ms4000000974863257 来自江西省

    under review两个多月了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2109630, encodeId=ed9c21096301e, content=有没有战友12月底修回的,到现在还没有收到回信?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c438367317, createdName=ms3000000310137729, createdTime=Tue Jan 10 09:26:49 CST 2023, time=2023-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114776, encodeId=78812114e7685, content=under review两个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Wed Feb 15 18:13:05 CST 2023, time=2023-02-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2113622, encodeId=2792211362243, content=23年起有伙伴被cells接收吗?问了几个人,不明原因审稿后待决定pending10-40天不等,很害怕,最近又开始控制中国稿件了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230126/2c0a7a41db0c42278cbcd3d3584dc3a3/8ac4d58bd64743f599a1e014c4bb7168.jpg, createdBy=684f6549008, createdName=豌豆嘎嘣脆, createdTime=Wed Feb 08 15:30:28 CST 2023, time=2023-02-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了,这么慢吗,这是在分配编辑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113477, encodeId=dd0521134e7f6, content=要求wb整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e298427966, createdName=ms8000000060323396, createdTime=Tue Feb 07 14:48:45 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向:肠道菌群<br>经验分享:Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2089804, encodeId=8bea20898043d, content=有大修后被拒的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 22 17:04:05 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向:细胞信号;分子生物学<br>经验分享:Under review 是外审还是编辑内审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审,两个审稿人意见还好(审稿人1:接受前需要做出一些必要的修改;审稿人2:我同意接收,但需要一些改动),状态持续pending decision半个多月(这个状态似乎是不乐观?),然后状态又突然变回under review,编辑说是在寻找第三个审稿人<br>这样还有戏吗(叹气), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2106393, encodeId=e1e12106393cf, content=有没有战友一审一个月,拒稿建议修改重投啊,这种有没有戏啊,求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Fri Dec 16 21:15:43 CST 2022, time=2022-12-16, status=1, ipAttribution=重庆)]
    2023-02-08 豌豆嘎嘣脆 来自辽宁省

    23年起有伙伴被cells接收吗?问了几个人,不明原因审稿后待决定pending10-40天不等,很害怕,最近又开始控制中国稿件了吗?

    21

    展开21条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2109630, encodeId=ed9c21096301e, content=有没有战友12月底修回的,到现在还没有收到回信?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c438367317, createdName=ms3000000310137729, createdTime=Tue Jan 10 09:26:49 CST 2023, time=2023-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114776, encodeId=78812114e7685, content=under review两个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Wed Feb 15 18:13:05 CST 2023, time=2023-02-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2113622, encodeId=2792211362243, content=23年起有伙伴被cells接收吗?问了几个人,不明原因审稿后待决定pending10-40天不等,很害怕,最近又开始控制中国稿件了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230126/2c0a7a41db0c42278cbcd3d3584dc3a3/8ac4d58bd64743f599a1e014c4bb7168.jpg, createdBy=684f6549008, createdName=豌豆嘎嘣脆, createdTime=Wed Feb 08 15:30:28 CST 2023, time=2023-02-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了,这么慢吗,这是在分配编辑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113477, encodeId=dd0521134e7f6, content=要求wb整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e298427966, createdName=ms8000000060323396, createdTime=Tue Feb 07 14:48:45 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向:肠道菌群<br>经验分享:Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2089804, encodeId=8bea20898043d, content=有大修后被拒的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 22 17:04:05 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向:细胞信号;分子生物学<br>经验分享:Under review 是外审还是编辑内审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审,两个审稿人意见还好(审稿人1:接受前需要做出一些必要的修改;审稿人2:我同意接收,但需要一些改动),状态持续pending decision半个多月(这个状态似乎是不乐观?),然后状态又突然变回under review,编辑说是在寻找第三个审稿人<br>这样还有戏吗(叹气), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2106393, encodeId=e1e12106393cf, content=有没有战友一审一个月,拒稿建议修改重投啊,这种有没有戏啊,求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Fri Dec 16 21:15:43 CST 2022, time=2022-12-16, status=1, ipAttribution=重庆)]
    2022-12-13 庸医小郝 来自湖北省

    Pending review三天了,这么慢吗,这是在分配编辑嘛?

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2109630, encodeId=ed9c21096301e, content=有没有战友12月底修回的,到现在还没有收到回信?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c438367317, createdName=ms3000000310137729, createdTime=Tue Jan 10 09:26:49 CST 2023, time=2023-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114776, encodeId=78812114e7685, content=under review两个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Wed Feb 15 18:13:05 CST 2023, time=2023-02-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2113622, encodeId=2792211362243, content=23年起有伙伴被cells接收吗?问了几个人,不明原因审稿后待决定pending10-40天不等,很害怕,最近又开始控制中国稿件了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230126/2c0a7a41db0c42278cbcd3d3584dc3a3/8ac4d58bd64743f599a1e014c4bb7168.jpg, createdBy=684f6549008, createdName=豌豆嘎嘣脆, createdTime=Wed Feb 08 15:30:28 CST 2023, time=2023-02-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了,这么慢吗,这是在分配编辑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113477, encodeId=dd0521134e7f6, content=要求wb整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e298427966, createdName=ms8000000060323396, createdTime=Tue Feb 07 14:48:45 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向:肠道菌群<br>经验分享:Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2089804, encodeId=8bea20898043d, content=有大修后被拒的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 22 17:04:05 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向:细胞信号;分子生物学<br>经验分享:Under review 是外审还是编辑内审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审,两个审稿人意见还好(审稿人1:接受前需要做出一些必要的修改;审稿人2:我同意接收,但需要一些改动),状态持续pending decision半个多月(这个状态似乎是不乐观?),然后状态又突然变回under review,编辑说是在寻找第三个审稿人<br>这样还有戏吗(叹气), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2106393, encodeId=e1e12106393cf, content=有没有战友一审一个月,拒稿建议修改重投啊,这种有没有戏啊,求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Fri Dec 16 21:15:43 CST 2022, time=2022-12-16, status=1, ipAttribution=重庆)]
    2023-02-07 ms8000000060323396 来自重庆

    要求wb整膜吗

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2109630, encodeId=ed9c21096301e, content=有没有战友12月底修回的,到现在还没有收到回信?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c438367317, createdName=ms3000000310137729, createdTime=Tue Jan 10 09:26:49 CST 2023, time=2023-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114776, encodeId=78812114e7685, content=under review两个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Wed Feb 15 18:13:05 CST 2023, time=2023-02-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2113622, encodeId=2792211362243, content=23年起有伙伴被cells接收吗?问了几个人,不明原因审稿后待决定pending10-40天不等,很害怕,最近又开始控制中国稿件了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230126/2c0a7a41db0c42278cbcd3d3584dc3a3/8ac4d58bd64743f599a1e014c4bb7168.jpg, createdBy=684f6549008, createdName=豌豆嘎嘣脆, createdTime=Wed Feb 08 15:30:28 CST 2023, time=2023-02-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了,这么慢吗,这是在分配编辑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113477, encodeId=dd0521134e7f6, content=要求wb整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e298427966, createdName=ms8000000060323396, createdTime=Tue Feb 07 14:48:45 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向:肠道菌群<br>经验分享:Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2089804, encodeId=8bea20898043d, content=有大修后被拒的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 22 17:04:05 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向:细胞信号;分子生物学<br>经验分享:Under review 是外审还是编辑内审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审,两个审稿人意见还好(审稿人1:接受前需要做出一些必要的修改;审稿人2:我同意接收,但需要一些改动),状态持续pending decision半个多月(这个状态似乎是不乐观?),然后状态又突然变回under review,编辑说是在寻找第三个审稿人<br>这样还有戏吗(叹气), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2106393, encodeId=e1e12106393cf, content=有没有战友一审一个月,拒稿建议修改重投啊,这种有没有戏啊,求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Fri Dec 16 21:15:43 CST 2022, time=2022-12-16, status=1, ipAttribution=重庆)]
    2023-01-02 ms4000000974863257 来自江西省

    偏重的研究方向:肠道菌群
    经验分享:Under review到底送外审了嘛

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2109630, encodeId=ed9c21096301e, content=有没有战友12月底修回的,到现在还没有收到回信?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c438367317, createdName=ms3000000310137729, createdTime=Tue Jan 10 09:26:49 CST 2023, time=2023-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114776, encodeId=78812114e7685, content=under review两个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Wed Feb 15 18:13:05 CST 2023, time=2023-02-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2113622, encodeId=2792211362243, content=23年起有伙伴被cells接收吗?问了几个人,不明原因审稿后待决定pending10-40天不等,很害怕,最近又开始控制中国稿件了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230126/2c0a7a41db0c42278cbcd3d3584dc3a3/8ac4d58bd64743f599a1e014c4bb7168.jpg, createdBy=684f6549008, createdName=豌豆嘎嘣脆, createdTime=Wed Feb 08 15:30:28 CST 2023, time=2023-02-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了,这么慢吗,这是在分配编辑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113477, encodeId=dd0521134e7f6, content=要求wb整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e298427966, createdName=ms8000000060323396, createdTime=Tue Feb 07 14:48:45 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向:肠道菌群<br>经验分享:Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2089804, encodeId=8bea20898043d, content=有大修后被拒的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 22 17:04:05 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向:细胞信号;分子生物学<br>经验分享:Under review 是外审还是编辑内审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审,两个审稿人意见还好(审稿人1:接受前需要做出一些必要的修改;审稿人2:我同意接收,但需要一些改动),状态持续pending decision半个多月(这个状态似乎是不乐观?),然后状态又突然变回under review,编辑说是在寻找第三个审稿人<br>这样还有戏吗(叹气), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2106393, encodeId=e1e12106393cf, content=有没有战友一审一个月,拒稿建议修改重投啊,这种有没有戏啊,求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Fri Dec 16 21:15:43 CST 2022, time=2022-12-16, status=1, ipAttribution=重庆)]
    2022-09-22 ms4000001710795128

    有大修后被拒的吗

    8

    展开8条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2109630, encodeId=ed9c21096301e, content=有没有战友12月底修回的,到现在还没有收到回信?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c438367317, createdName=ms3000000310137729, createdTime=Tue Jan 10 09:26:49 CST 2023, time=2023-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114776, encodeId=78812114e7685, content=under review两个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Wed Feb 15 18:13:05 CST 2023, time=2023-02-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2113622, encodeId=2792211362243, content=23年起有伙伴被cells接收吗?问了几个人,不明原因审稿后待决定pending10-40天不等,很害怕,最近又开始控制中国稿件了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230126/2c0a7a41db0c42278cbcd3d3584dc3a3/8ac4d58bd64743f599a1e014c4bb7168.jpg, createdBy=684f6549008, createdName=豌豆嘎嘣脆, createdTime=Wed Feb 08 15:30:28 CST 2023, time=2023-02-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了,这么慢吗,这是在分配编辑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113477, encodeId=dd0521134e7f6, content=要求wb整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e298427966, createdName=ms8000000060323396, createdTime=Tue Feb 07 14:48:45 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向:肠道菌群<br>经验分享:Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2089804, encodeId=8bea20898043d, content=有大修后被拒的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 22 17:04:05 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向:细胞信号;分子生物学<br>经验分享:Under review 是外审还是编辑内审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审,两个审稿人意见还好(审稿人1:接受前需要做出一些必要的修改;审稿人2:我同意接收,但需要一些改动),状态持续pending decision半个多月(这个状态似乎是不乐观?),然后状态又突然变回under review,编辑说是在寻找第三个审稿人<br>这样还有戏吗(叹气), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2106393, encodeId=e1e12106393cf, content=有没有战友一审一个月,拒稿建议修改重投啊,这种有没有戏啊,求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Fri Dec 16 21:15:43 CST 2022, time=2022-12-16, status=1, ipAttribution=重庆)]
    2022-07-23 ms3000000915988761

    偏重的研究方向:细胞信号;分子生物学
    经验分享:Under review 是外审还是编辑内审?

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2109630, encodeId=ed9c21096301e, content=有没有战友12月底修回的,到现在还没有收到回信?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c438367317, createdName=ms3000000310137729, createdTime=Tue Jan 10 09:26:49 CST 2023, time=2023-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114776, encodeId=78812114e7685, content=under review两个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Wed Feb 15 18:13:05 CST 2023, time=2023-02-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2113622, encodeId=2792211362243, content=23年起有伙伴被cells接收吗?问了几个人,不明原因审稿后待决定pending10-40天不等,很害怕,最近又开始控制中国稿件了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230126/2c0a7a41db0c42278cbcd3d3584dc3a3/8ac4d58bd64743f599a1e014c4bb7168.jpg, createdBy=684f6549008, createdName=豌豆嘎嘣脆, createdTime=Wed Feb 08 15:30:28 CST 2023, time=2023-02-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了,这么慢吗,这是在分配编辑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113477, encodeId=dd0521134e7f6, content=要求wb整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e298427966, createdName=ms8000000060323396, createdTime=Tue Feb 07 14:48:45 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向:肠道菌群<br>经验分享:Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2089804, encodeId=8bea20898043d, content=有大修后被拒的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 22 17:04:05 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向:细胞信号;分子生物学<br>经验分享:Under review 是外审还是编辑内审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审,两个审稿人意见还好(审稿人1:接受前需要做出一些必要的修改;审稿人2:我同意接收,但需要一些改动),状态持续pending decision半个多月(这个状态似乎是不乐观?),然后状态又突然变回under review,编辑说是在寻找第三个审稿人<br>这样还有戏吗(叹气), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2106393, encodeId=e1e12106393cf, content=有没有战友一审一个月,拒稿建议修改重投啊,这种有没有戏啊,求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Fri Dec 16 21:15:43 CST 2022, time=2022-12-16, status=1, ipAttribution=重庆)]
    2022-12-11 12433741m11(暂无昵称) 来自湖北省

    投稿后初审,两个审稿人意见还好(审稿人1:接受前需要做出一些必要的修改;审稿人2:我同意接收,但需要一些改动),状态持续pending decision半个多月(这个状态似乎是不乐观?),然后状态又突然变回under review,编辑说是在寻找第三个审稿人
    这样还有戏吗(叹气)

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2109630, encodeId=ed9c21096301e, content=有没有战友12月底修回的,到现在还没有收到回信?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c438367317, createdName=ms3000000310137729, createdTime=Tue Jan 10 09:26:49 CST 2023, time=2023-01-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114776, encodeId=78812114e7685, content=under review两个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Wed Feb 15 18:13:05 CST 2023, time=2023-02-15, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2113622, encodeId=2792211362243, content=23年起有伙伴被cells接收吗?问了几个人,不明原因审稿后待决定pending10-40天不等,很害怕,最近又开始控制中国稿件了吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230126/2c0a7a41db0c42278cbcd3d3584dc3a3/8ac4d58bd64743f599a1e014c4bb7168.jpg, createdBy=684f6549008, createdName=豌豆嘎嘣脆, createdTime=Wed Feb 08 15:30:28 CST 2023, time=2023-02-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了,这么慢吗,这是在分配编辑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2113477, encodeId=dd0521134e7f6, content=要求wb整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e298427966, createdName=ms8000000060323396, createdTime=Tue Feb 07 14:48:45 CST 2023, time=2023-02-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向:肠道菌群<br>经验分享:Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2089804, encodeId=8bea20898043d, content=有大修后被拒的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98af5487361, createdName=ms4000001710795128, createdTime=Thu Sep 22 17:04:05 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向:细胞信号;分子生物学<br>经验分享:Under review 是外审还是编辑内审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审,两个审稿人意见还好(审稿人1:接受前需要做出一些必要的修改;审稿人2:我同意接收,但需要一些改动),状态持续pending decision半个多月(这个状态似乎是不乐观?),然后状态又突然变回under review,编辑说是在寻找第三个审稿人<br>这样还有戏吗(叹气), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2106393, encodeId=e1e12106393cf, content=有没有战友一审一个月,拒稿建议修改重投啊,这种有没有戏啊,求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Fri Dec 16 21:15:43 CST 2022, time=2022-12-16, status=1, ipAttribution=重庆)]
    2022-12-16 ms8000000030832967 来自重庆

    有没有战友一审一个月,拒稿建议修改重投啊,这种有没有戏啊,求解答

    0

共210条页码: 2/21页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分